Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI Therapy
ClinicalTrials.gov study NCT03042221. IPD Sharing: NO. Countries: 1. Publications: 0.
Weekly Use First-generation EGFR-TKI in the Treatment of EGFR-TKI Acquired Resistance Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT02575560. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody, Cetuximab, in Combination With Gemcitabine/Carboplatin in Patients With Stage IV Lung Cancer
ClinicalTrials.gov study NCT01004731. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Umbrella, Modular Study Based on Epidermal Growth Factor Receptor (EGFR) Mutation Status
ClinicalTrials.gov study NCT00903734. IPD Sharing: Not stated. Countries: 1. Publications: 0.
STUDY OBSERVATIONAL OF ERLOTINIB AS SECOND LINE TREATMENT IN PATIENTS WITH SQUAMOUS NSCLC AND EGFR NATIVE
ClinicalTrials.gov study NCT02328391. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Onartuzumab in Combination With Erlotinib in Patients With MET-Positive Stage IIIB or IV Non-Small Cell Lung Cancer Carrying an Activating Epidermal Growth Factor Receptor (EGFR) Mutation
ClinicalTrials.gov study NCT01887886. IPD Sharing: Not stated. Countries: 8. Publications: 0.
Firmonertinib Combined With Definitive Radiotherapy in Stage III Unresectable EGFR Uncommon Mutant Pulmonary Adenocarcinoma
ClinicalTrials.gov study NCT07314216. IPD Sharing: NO. Countries: 1. Publications: 0.
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
ClinicalTrials.gov study NCT03191149. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Detection of Resistance Mechanisms in Cerebrospinal Fluid for EGFR-mutant, ALK- and ROS1-rearranged
ClinicalTrials.gov study NCT05116618. IPD Sharing: NO. Countries: 1. Publications: 0.
EGFR Inhibition Using Weekly Erlotinib for Recurrent Malignant Gliomas
ClinicalTrials.gov study NCT01257594. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of Furmonertinib in Patients With Locally Advanced or Metastatic NSCLC With EGFR Exon 20 Insertion
ClinicalTrials.gov study NCT05466149. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Comparing BL-B01D1 With Docetaxel in Patients With Unresectable Locally Advanced or Metastatic EGFR Wild-type Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT06382129. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Pharmacokinetics of Recombinant Anti-EGFr Antibody in Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT03017807. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of MRG003 in the Treatment of EGFR-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer
ClinicalTrials.gov study NCT04838964. IPD Sharing: NO. Countries: 1. Publications: 0.
ORIENT-31 Regimen in Combination with SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs
ClinicalTrials.gov study NCT06775743. IPD Sharing: Not stated. Countries: 0. Publications: 0.
(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC
ClinicalTrials.gov study NCT05153408. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Sintilimab or Placebo in Combination With Chemotherapy as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer With Wild-type EGFR After Failure With Plat
ClinicalTrials.gov study NCT03863483. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN8)
ClinicalTrials.gov study NCT07079475. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficiency of γδ T Cell Against Non Small Lung Cancer ( Without EGFR Mutation)
ClinicalTrials.gov study NCT02425748. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of BEBT-109 in Subjects With Non-Small Cell Lung Cancer Carrying EGFR Exon 20 Insertion Mutations
ClinicalTrials.gov study NCT06514027. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.